Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$908M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$706M |
| 3 |
Truist Financial
TFC
|
+$462M |
| 4 |
Amazon
AMZN
|
+$348M |
| 5 |
ServiceNow
NOW
|
+$268M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$130M |
| 5 |
Intuitive Surgical
ISRG
|
+$117M |
Sector Composition
| 1 | Technology | 19.82% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Lineage Cell Therapeutics
LCTX
$288M
| $1.4M | ﹤0.01% |
1,568,727
+27,939
| +2% | +$24.9K |
|
|
BCEL
3102
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.4M | ﹤0.01% |
90,242
+45,086
| +100% | +$697K |
|
3103
Exicure
XCUR
$24.7M
| $1.39M | ﹤0.01% |
3,231
+722
| +29% | +$309K |
|
3104
Cytosorbents Corp
CTSO
$62.1M
| $1.38M | ﹤0.01% |
359,652
+6,891
| +2% | +$26.5K |
|
3105
Exagen
XGN
$216M
| $1.38M | ﹤0.01% |
+54,432
| New | +$1.38M |
|
|
LJPC
3106
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.38M | ﹤0.01% |
350,261
+8,581
| +3% | +$33.7K |
|
|
NESR
3107
National Energy Services Reunited Corp. Ordinary Shares
NESR
$982M
| $1.37M | ﹤0.01% |
150,271
+23,406
| +18% | +$213K |
|
3108
Enel Chile
ENIC
$5.02B
| $1.37M | ﹤0.01% |
288,379
+69,093
| +32% | +$328K |
|
3109
Potbelly
PBPB
$515M
| $1.36M | ﹤0.01% |
322,992
+14,721
| +5% | +$62.1K |
|
3110
CB Financial Services
CBFV
$165M
| $1.36M | ﹤0.01% |
45,164
+251
| +0.6% | +$7.56K |
|
3111
Orion Group Holdings
ORN
$292M
| $1.36M | ﹤0.01% |
262,061
-1,720
| -0.7% | -$8.93K |
|
3112
Marine Products Corp
MPX
$320M
| $1.36M | ﹤0.01% |
94,125
+1,592
| +2% | +$22.9K |
|
|
GSB
3113
DELISTED
GlobalSCAPE, Inc.
GSB
| $1.35M | ﹤0.01% |
137,659
-11,117
| -7% | -$109K |
|
|
ENZ
3114
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.35M | ﹤0.01% |
513,792
+2,927
| +0.6% | +$7.7K |
|
|
SHSP
3115
DELISTED
SharpSpring, Inc.
SHSP
| $1.34M | ﹤0.01% |
116,492
+7,111
| +7% | +$81.6K |
|
|
IAE
3116
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$77.6M
| $1.33M | ﹤0.01% |
156,956
+58,310
| +59% | +$496K |
|
3117
GSI Technology
GSIT
$89.6M
| $1.33M | ﹤0.01% |
187,072
+2,320
| +1% | +$16.4K |
|
|
SRT
3118
DELISTED
Startek Inc.
SRT
| $1.33M | ﹤0.01% |
166,165
+3,561
| +2% | +$28.4K |
|
3119
Twin Disc
TWIN
$192M
| $1.32M | ﹤0.01% |
119,741
+2,678
| +2% | +$29.5K |
|
|
EMWP
3120
DELISTED
Eros Media World PLC
EMWP
| $1.31M | ﹤0.01% |
19,362
-177
| -0.9% | -$12K |
|
|
BLDP
3121
Ballard Power Systems
BLDP
$583M
| $1.31M | ﹤0.01% |
183,454
+2,802
| +2% | +$20K |
|
3122
United Security Bancshares
UBFO
$169M
| $1.3M | ﹤0.01% |
121,500
+278
| +0.2% | +$2.98K |
|
3123
PLDT
PHI
$4.22B
| $1.3M | ﹤0.01% |
+65,145
| New | +$1.3M |
|
3124
Avalo Therapeutics
AVTX
$152M
| $1.3M | ﹤0.01% |
84
+1
| +1% | +$15.4K |
|
3125
Global Water Resources
GWRS
$271M
| $1.3M | ﹤0.01% |
98,531
-656
| -0.7% | -$8.62K |
|